Siemens Healthineers oferuje szeroki wachlarz nowatorskich rozwiązań do hemostazy, które do każdego laboratorium będą pasować tak, jakby były wykonane na miarę.
High-volume, fully-automated solution featuring PSI technology and automation connectivity
Accurate and Precise Coagulation Testing
Mid-volume, fully automated solution featuring smartly designed technologies including PSI technology
The Sysmex CS-2000i/CS-2100i Systems reduce the need for repeat testing through PSI checks and multi-wavelength technology
Big performance from the smallest instrument in its class
Automated assessment of platelet dysfunction in 5 – 8 minutes, including P2Y12 assessment
Small, high-performance system
Innovation in D-dimer testing that goes beyond the expected
Ready-to-use liquid heparin testing: fewer steps to precise results
State-of-the-art antithrombin testing
Supporting labs in the diagnosis, treatment, and management of coagulation abnormalities in COVID-19 patients.
Supporting early diagnosis, treatment, and management of COVID-19 infections
Manageable, reliable, and accessible with easy-to-use, standardized testing solutions. Learn more.
Read more about how Atellica® COAG 360 System's quantification of HIL plasma indices can help reduce diagnostic errors.
The INNOVANCE® line is an example of our longstanding commitment to help answer the concrete challenges of laboratories like yours.
Learn more about thrombosis risk factors and see how reliable diagnostic methods can help to stop deadly clots.
Analizy przypadków badań wykonywanych w systemach hemostazy
Watch the animation to learn how Siemens can provide a complete solution for automating workflow.
Bądź na bieżąco o trendach i technikach badaniach krzepnięcia osocza dzięki kampusowi online.
Pozwól, by Siemens wyposażył twoje laboratorium w kompleksowy zestaw urządzeń do badania hemostazy.
Fundamentem naszej firmy są nowatorskie analizatory, odczynniki, oprogramowanie i wsparcie.
View the process of clot formation and learn about the fundamental role that thrombin plays in driving and regulating clotting activity.
View the processes involved in thrombophilia, a condition that leads to unwanted clot development, and how the activity of therapeutic agents can counteract its effects.